Adverse Drug Reaction Classification System

ADR Ontology
ADR Term Dermatitis bullous
ADR ID BADD_A01220
ADR Hierarchy
23      Skin and subcutaneous tissue disorders
23.03      Epidermal and dermal conditions
23.03.01      Bullous conditions
23.03.01.002      Dermatitis bullous
Description Skin diseases characterized by local or general distributions of blisters. They are classified according to the site and mode of blister formation. Lesions can appear spontaneously or be precipitated by infection, trauma, or sunlight. Etiologies include immunologic and genetic factors. (From Scientific American Medicine, 1990) [MeSH]
MedDRA Code 10012441
MeSH ID D012872; D001768
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE)
Synonym
Bulla auricular | Bulla dorsum manus | Bullous dermatitis | Bullous dermatoses | Bullous disorder | Bullous eruption | Bullous lesions | Bullous rash | Bullous rash both arms | Bullous rash upper chest | Dermatitis bullous | Dermatosis bullous | Erythema bullosum | Other specified bullous dermatoses | Rash bullous | Rash vesiculo-bullous | Rash vesiculobullous | Unspecified bullous dermatoses | Vesiculo-bullous eruption | Vesiculo-bullous rash | Vesiculobullous rash | Skin Diseases, Vesiculobullous | Skin Disease, Vesiculobullous | Vesiculobullous Skin Disease | Vesiculobullous Skin Diseases | Vesiculobullous Dermatoses | Dermatoses, Vesiculobullous | Skin Diseases, Bullous | Bullous Skin Disease | Skin Disease, Bullous | Bullous Skin Diseases | Bullous Dermatoses | Dermatoses, Bullous | Vesicular Skin Diseases | Skin Disease, Vesicular | Vesicular Skin Disease | Skin Diseases, Vesicular | Pustular Dermatosis, Subcorneal | Dermatoses, Subcorneal Pustular | Dermatosis, Subcorneal Pustular | Pustular Dermatoses, Subcorneal | Subcorneal Pustular Dermatoses | Sneddon-Wilkinson Disease | Sneddon Wilkinson Disease | Subcorneal Pustular Dermatosis
ADR Related Proteins
Protein Name UniProt AC TTD Target ID
Not AvailableNot AvailableNot Available
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D00519Colesevelam hydrochloride--
BADD_D00543Cyclizine--
BADD_D00549Cyclophosphamide--
BADD_D00551Cyclosporine--
BADD_D00560Cytarabine0.000533%
BADD_D00562Cytomegalovirus immune globulin (human)--
BADD_D00564Dabigatran etexilate--
BADD_D00566Dabrafenib--
BADD_D00567Dabrafenib mesylate--
BADD_D00568Dacarbazine0.000533%
BADD_D00575Dalteparin sodium--
BADD_D00581Daptomycin--
BADD_D00589Dasatinib--
BADD_D00594Deferasirox--
BADD_D00603Delavirdine--
BADD_D00604Delavirdine mesylate--
BADD_D00623Dexamethasone--
BADD_D00624Dexamethasone phosphate--
BADD_D00653Diclofenac0.000237%
BADD_D00680Dimethyl fumarate0.008252%
BADD_D00696Divalproex sodium--
BADD_D00699Docetaxel--
BADD_D00706Donepezil--
BADD_D00707Donepezil hydrochloride--
BADD_D00714Dothiepin hydrochloride--
BADD_D00723Doxorubicin--
BADD_D00724Doxorubicin hydrochloride--
BADD_D00734Duloxetine--
BADD_D00749Efavirenz--
BADD_D00751Eflornithine--
The 3th Page    First    Pre   3 4 5 6 7    Next   Last    Total 12 Pages